Related Experiment Video
Updated: Jul 18, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse
Jay A Grobler1, Geetha Dornadula, Michele R Rice
1Department of Antiviral Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA. jay_grobler@merck.com
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) potently block HIV-1 replication by specifically inhibiting plus-strand DNA initiation. This targeted mechanism, rather than general reverse transcription inhibition, is key to their antiviral activity.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Non-nucleoside reverse transcriptase inhibitors (NNRTIs) are critical antiretroviral drugs targeting HIV-1.
- NNRTIs are known allosteric inhibitors of HIV-1 reverse transcriptase (RT).
- Their mechanism of inhibiting reverse transcription has been thought to be stochastic and substrate-dependent.
Purpose of the Study:
- To investigate the precise mechanism by which NNRTIs inhibit HIV-1 reverse transcription.
- To elucidate the role of plus-strand DNA initiation in NNRTI-mediated inhibition.
- To identify structural determinants of NNRTI sensitivity during initiation.
Main Methods:
- In vitro biochemical assays using modified plus-strand initiation substrates.
- Comparison of NNRTI inhibition with RNA vs. DNA primers.
- Testing against wild-type and NNRTI-resistant HIV-1 reverse transcriptase variants.
Main Results:
- NNRTIs demonstrated potent inhibition of plus-strand DNA initiation.
- Inhibition was significantly greater with an RNA PPT primer compared to a DNA primer.
- NNRTI sensitivity was observed with wild-type RT but not with resistant enzymes.
- Structural elements influencing NNRTI sensitivity during initiation were identified.
Conclusions:
- Specific inhibition of plus-strand DNA initiation is a key mechanism of NNRTI action.
- This targeted inhibition contributes significantly to blocking HIV-1 replication.
- Understanding this mechanism can inform the development of new antiretroviral therapies.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
13:07Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
Published on: January 30, 2019
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Viruses with RNA Genomes
Inhibitors Of Virion Release
Size and Structure of Viral Genomes